Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...